Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors

Kuczmarski, R.J.; Flegal, K.M. Criteria for definition of overweight in transition: background and recommendations for the United States. Am. J. Clin. Nutr., 2000, 72(5), 1074-1081.
[http://dx.doi.org/10.1093/ajcn/72.5.1074] [PMID: 11063431]

Guilcher, S.J.T.; Kaufman-Shriqui, V.; Hwang, J.; O’Campo, P.; Matheson, F.I.; Glazier, R.H.; Booth, G.L. The association between social cohesion in the neighborhood and body mass index (BMI): an examination of gendered differences among urban-dwelling Canadians. Prev. Med., 2017, 99, 293-298.
[http://dx.doi.org/10.1016/j.ypmed.2017.02.022] [PMID: 28232099]

Hurt, R.T.; Frazier, T.H.; McClave, S.A.; Kaplan, L.M. Obesity epidemic: overview, pathophysiology, and the intensive care unit conundrum. JPEN J. Parenter. Enteral Nutr., 2011, 35(5)(Suppl.), 4S-13S.
[http://dx.doi.org/10.1177/0148607111415110] [PMID: 21881014]

Swinburn, B.A.; Sacks, G.; Hall, K.D.; McPherson, K.; Finegood, D.T.; Moodie, M.L.; Gortmaker, S.L. The global obesity pandemic: shaped by global drivers and local environments. Lancet, 2011, 378(9793), 804-814.
[http://dx.doi.org/10.1016/S0140-6736(11)60813-1] [PMID: 21872749]

Flegal, K.M.; Kruszon-Moran, D.; Carroll, M.D.; Fryar, C.D.; Ogden, C.L. Trends in obesity among adults in the United States, 2005 to 2014. JAMA, 2016, 315(21), 2284-2291.
[http://dx.doi.org/10.1001/jama.2016.6458] [PMID: 27272580]

Castro, A.M.; Toledo-Rojas, A.A.; Macedo-De La Concha, L.E.; Inclán-Rubio, V. La obesidad infantil, un problema de salud multisistémico. Rev. Med. Hosp. Gen. (Mex.), 2012, 75(1), 41-49.

Choy, E.H.; Panayi, G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med., 2001, 344(12), 907-916.
[http://dx.doi.org/10.1056/NEJM200103223441207] [PMID: 11259725]

Sureda, A.; Martorell, M.; Capó, X.; Monserrat-Mesquida, M.; Quetglas-Llabrés, M.M.; Rasekhian, M.; Nabavi, S.M.; Tejada, S. Antitumor effects of triterpenes in hepatocellular carcinoma. Curr. Med. Chem., 2020. Epub ahead of print
[http://dx.doi.org/10.2174/0929867327666200602132000] [PMID: 32484765]

Cheng, K.; Liu, C.-F.; Rao, G.-W. Antiangiogenic agents: a review on vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors. Curr. Med. Chem., 2020. Epub ahead of print.
[http://dx.doi.org/10.2174/0929867327666200514082425] [PMID: 32407259]

Bitencourt-Ferreira, G.; Rizzotto, C.; de Azevedo, W.F. Jr. Machine learning-based scoring functions. Development and applications with SAnDReS. Curr. Med. Chem., 2020. Epub ahead of print
[http://dx.doi.org/10.2174/0929867327666200515101820] [PMID: 32410551]

Bitencourt-Ferreira, G.; da Silva, A.D.; de Azevedo, W.F. Jr. Application of machine learning techniques to predict binding affinity for drug targets. A study of cyclin-dependent kinase 2. Curr. Med. Chem., 2021, 28(2), 253-265.
[http://dx.doi.org/10.2174/2213275912666191102162959] [PMID: 31729287]

Volkart, P.A.; Bitencourt-Ferreira, G.; Souto, A.A.; de Azevedo, W.F. Jr. Cyclin-dependent kinase 2 in cellular senescence and cancer. A structural and functional review. Curr. Drug Targets, 2019, 20(7), 716-726.
[http://dx.doi.org/10.2174/1389450120666181204165344] [PMID: 30516105]

Levin, N.M.B.; Pintro, V.O.; Bitencourt-Ferreira, G.; de Mattos, B.B.; de Castro Silvério, A.; de Azevedo, W.F. Jr. Development of CDK-targeted scoring functions for prediction of binding affinity. Biophys. Chem., 2018, 235, 1-8.
[http://dx.doi.org/10.1016/j.bpc.2018.01.004] [PMID: 29407904]

de Ávila, M.B.; Xavier, M.M.; Pintro, V.O.; de Azevedo, W.F. Jr. Supervised machine learning techniques to predict binding affinity. A study for cyclin-dependent kinase 2. Biochem. Biophys. Res. Commun., 2017, 494(1-2), 305-310.
[http://dx.doi.org/10.1016/j.bbrc.2017.10.035] [PMID: 29017921]

Canduri, F.; Perez, P.C.; Caceres, R.A.; de Azevedo, W.F. Jr. Protein kinases as targets for antiparasitic chemotherapy drugs. Curr. Drug Targets, 2007, 8(3), 389-398.
[http://dx.doi.org/10.2174/138945007780058979] [PMID: 17348832]

Shoelson, S.E.; Lee, J.; Yuan, M. Inflammation and the IKK β/I κ B/NF-κ B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord., 2003, 27(S3)(Suppl. 3), S49-S52.
[http://dx.doi.org/10.1038/sj.ijo.0802501] [PMID: 14704745]

Hotamisligil, G.S.; Shargill, N.S.; Spiegelman, B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 1993, 259(5091), 87-91.
[http://dx.doi.org/10.1126/science.7678183] [PMID: 7678183]

Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W., Jr Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest., 2003, 112(12), 1796-1808.
[http://dx.doi.org/10.1172/JCI200319246] [PMID: 14679176]

West, M. Dead adipocytes and metabolic dysfunction: recent progress. Curr. Opin. Endocrinol. Diabetes Obes., 2009, 16(2), 178-182.
[http://dx.doi.org/10.1097/MED.0b013e3283292327] [PMID: 19306530]

Cinti, S.; Mitchell, G.; Barbatelli, G.; Murano, I.; Ceresi, E.; Faloia, E.; Wang, S.; Fortier, M.; Greenberg, A.S.; Obin, M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res., 2005, 46(11), 2347-2355.
[http://dx.doi.org/10.1194/jlr.M500294-JLR200] [PMID: 16150820]

Surmi, B.K.; Hasty, A.H. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol., 2008, 3(5), 545-556.
[http://dx.doi.org/10.2217/17460875.3.5.545] [PMID: 18978945]

Elgazar-Carmon, V.; Rudich, A.; Hadad, N.; Levy, R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J. Lipid Res., 2008, 49(9), 1894-1903.
[http://dx.doi.org/10.1194/jlr.M800132-JLR200] [PMID: 18503031]

Galli, S.J.; Borregaard, N.; Wynn, T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol., 2011, 12(11), 1035-1044.
[http://dx.doi.org/10.1038/ni.2109] [PMID: 22012443]

Wu, D.; Molofsky, A.B.; Liang, H-E.; Ricardo-Gonzalez, R.R.; Jouihan, H.A.; Bando, J.K.; Chawla, A.; Locksley, R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science, 2011, 332(6026), 243-247.
[http://dx.doi.org/10.1126/science.1201475] [PMID: 21436399]

Winer, D.A.; Winer, S.; Shen, L.; Wadia, P.P.; Yantha, J.; Paltser, G.; Tsui, H.; Wu, P.; Davidson, M.G.; Alonso, M.N.; Leong, H.X.; Glassford, A.; Caimol, M.; Kenkel, J.A.; Tedder, T.F.; McLaughlin, T.; Miklos, D.B.; Dosch, H.M.; Engleman, E.G. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med., 2011, 17(5), 610-617.
[http://dx.doi.org/10.1038/nm.2353] [PMID: 21499269]

Lowe, G.; Woodward, M.; Hillis, G.; Rumley, A.; Li, Q.; Harrap, S.; Marre, M.; Hamet, P.; Patel, A.; Poulter, N.; Chalmers, J. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes, 2014, 63(3), 1115-1123.
[http://dx.doi.org/10.2337/db12-1625] [PMID: 24222348]

Moran, A.; Jacobs, D.R., Jr; Steinberger, J.; Hong, C-P.; Prineas, R.; Luepker, R.; Sinaiko, A.R. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes, 1999, 48(10), 2039-2044.
[http://dx.doi.org/10.2337/diabetes.48.10.2039] [PMID: 10512371]

Buchanan, T.A.; Metzger, B.E.; Freinkel, N.; Bergman, R.N. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am. J. Obstet. Gynecol., 1990, 162(4), 1008-1014.
[http://dx.doi.org/10.1016/0002-9378(90)91306-W] [PMID: 2183610]

Defronzo, R.A. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes, 1979, 28(12), 1095-1101.
[http://dx.doi.org/10.2337/diab.28.12.1095] [PMID: 510806]

Goodyear, L.J.; Kahn, B.B. Exercise, glucose transport, and insulin sensitivity. Annu. Rev. Med., 1998, 49(1), 235-261.
[http://dx.doi.org/10.1146/annurev.med.49.1.235] [PMID: 9509261]

Chen, M.; Bergman, R.N.; Porte, D., Jr Insulin resistance and β-cell dysfunction in aging: the importance of dietary carbohydrate. J. Clin. Endocrinol. Metab., 1988, 67(5), 951-957.
[http://dx.doi.org/10.1210/jcem-67-5-951] [PMID: 3053750]

Wellen, K.E.; Hotamisligil, G.S. Inflammation, stress, and diabetes. J. Clin. Invest., 2005, 115(5), 1111-1119.
[http://dx.doi.org/10.1172/JCI25102] [PMID: 15864338]

Scherer, P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 2006, 55(6), 1537-1545.
[http://dx.doi.org/10.2337/db06-0263] [PMID: 16731815]

Yang, Q.; Graham, T.E.; Mody, N.; Preitner, F.; Peroni, O.D.; Zabolotny, J.M.; Kotani, K.; Quadro, L.; Kahn, B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 2005, 436(7049), 356-362.
[http://dx.doi.org/10.1038/nature03711] [PMID: 16034410]

Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 2006, 116(7), 1784-1792.
[http://dx.doi.org/10.1172/JCI29126] [PMID: 16823476]

Fain, J.N.; Madan, A.K.; Hiler, M.L.; Cheema, P.; Bahouth, S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 2004, 145(5), 2273-2282.
[http://dx.doi.org/10.1210/en.2003-1336] [PMID: 14726444]

Mooney, R.A.; Senn, J.; Cameron, S.; Inamdar, N.; Boivin, L.M.; Shang, Y.; Furlanetto, R.W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem., 2001, 276(28), 25889-25893.
[http://dx.doi.org/10.1074/jbc.M010579200] [PMID: 11342531]

Perreault, M.; Marette, A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med., 2001, 7(10), 1138-1143.
[http://dx.doi.org/10.1038/nm1001-1138] [PMID: 11590438]

Carvalho-Filho, M.A.; Ueno, M.; Hirabara, S.M.; Seabra, A.B.; Carvalheira, J.B.; de Oliveira, M.G.; Velloso, L.A.; Curi, R.; Saad, M.J. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 2005, 54(4), 959-967.
[http://dx.doi.org/10.2337/diabetes.54.4.959] [PMID: 15793233]

Reaven, G.M.; Hollenbeck, C.; Jeng, C-Y.; Wu, M.S.; Chen, Y-D.I. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes, 1988, 37(8), 1020-1024.
[http://dx.doi.org/10.2337/diab.37.8.1020] [PMID: 3292322]

Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 1997, 46(1), 3-10.
[http://dx.doi.org/10.2337/diab.46.1.3] [PMID: 8971073]

Santomauro, A.T.; Boden, G.; Silva, M.E.; Rocha, D.M.; Santos, R.F.; Ursich, M.J.; Strassmann, P.G.; Wajchenberg, B.L. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes, 1999, 48(9), 1836-1841.
[http://dx.doi.org/10.2337/diabetes.48.9.1836] [PMID: 10480616]

Shulman, G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest., 2000, 106(2), 171-176.
[http://dx.doi.org/10.1172/JCI10583] [PMID: 10903330]

Schwartz, M.W.; Woods, S.C.; Porte, D., Jr; Seeley, R.J.; Baskin, D.G. Central nervous system control of food intake. Nature, 2000, 404(6778), 661-671.
[http://dx.doi.org/10.1038/35007534] [PMID: 10766253]

Pandit, R.; de Jong, J.W.; Vanderschuren, L.J.; Adan, R.A. Neurobiology of overeating and obesity: the role of melanocortins and beyond. Eur. J. Pharmacol., 2011, 660(1), 28-42.
[http://dx.doi.org/10.1016/j.ejphar.2011.01.034] [PMID: 21295024]

Wasim, M.; Fakhar, N. Leptin gene mutations in morbidly obese and severely lean individuals from Punjab, Pakistan. J. Obes. Weight Loss Ther., 2014, 4(4), 233.
[http://dx.doi.org/10.4172/2165-7904.1000233]]

Wasim, M. Role of leptin in obesity. J. Obes. Weight Loss Ther., 2015, 5(258), 2.
[http://dx.doi.org/10.4172/2165-7904.1000258]]

Montague, C.T.; Farooqi, I.S.; Whitehead, J.P.; Soos, M.A.; Rau, H.; Wareham, N.J.; Sewter, C.P.; Digby, J.E.; Mohammed, S.N.; Hurst, J.A.; Cheetham, C.H.; Earley, A.R.; Barnett, A.H.; Prins, J.B.; O’Rahilly, S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 1997, 387(6636), 903-908.
[http://dx.doi.org/10.1038/43185] [PMID: 9202122]

Yupanqui-Lozno, H.; Bastarrachea, R.A.; Yupanqui-Velazco, M.E.; Alvarez-Jaramillo, M.; Medina-Méndez, E.; Giraldo-Peña, A.P.; Arias-Serrano, A.; Torres-Forero, C.; Garcia-Ordoñez, A.M.; Mastronardi, C.A.; Restrepo, C.M.; Rodriguez-Ayala, E.; Nava-Gonzalez, E.J.; Arcos-Burgos, M.; Kent, J.W. Jr; Cole, S.A.; Licinio, J.; Celis-Regalado, L.G. Congenital leptin deficiency and leptin gene missense mutation found in two Colombian sisters with severe obesity. Genes (Basel), 2019, 10(5), 342.
[http://dx.doi.org/10.3390/genes10050342] [PMID: 31067764]

Álvarez-Castro, P.; Pena, L.; Cordido, F. Ghrelin in obesity, physiological and pharmacological considerations. Mini Rev. Med. Chem., 2013, 13(4), 541-552.
[http://dx.doi.org/10.2174/1389557511313040007] [PMID: 22931534]

Morrish, G.A.; Pai, M.P.; Green, B. The effects of obesity on drug pharmacokinetics in humans. Expert Opin. Drug Metab. Toxicol., 2011, 7(6), 697-706.
[http://dx.doi.org/10.1517/17425255.2011.570331] [PMID: 21417960]

Ghose, R. Clinical consequences of altered drug disposition in obesity. J. Clin. Trials, 2013, 2e107
[http://dx.doi.org/10.4172/2167-0870.1000e107]]

Tomankova, V.; Liskova, B.; Skalova, L.; Bartikova, H.; Bousova, I.; Jourova, L.; Anzenbacher, P.; Ulrichova, J.; Anzenbacherova, E. Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity. Life Sci., 2015, 133, 15-20.
[http://dx.doi.org/10.1016/j.lfs.2015.04.014] [PMID: 25998026]

Zhang, W.V.; Ramzan, I.; Murray, M. Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis. J. Pharmacol. Exp. Ther., 2007, 322(2), 770-777.
[http://dx.doi.org/10.1124/jpet.107.124024] [PMID: 17522342]

DuBois, B.N.; O’Tierney-Ginn, P.; Pearson, J.; Friedman, J.E.; Thornburg, K.; Cherala, G. Maternal obesity alters feto-placental cytochrome P4501A1 activity. Placenta, 2012, 33(12), 1045-1051.
[http://dx.doi.org/10.1016/j.placenta.2012.09.008] [PMID: 23046808]

Donato, M.T.; Jiménez, N.; Serralta, A.; Mir, J.; Castell, J.V.; Gómez-Lechón, M.J. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes. Toxicol. In Vitro, 2007, 21(2), 271-276.
[http://dx.doi.org/10.1016/j.tiv.2006.07.008] [PMID: 16950596]

Xu, C.; Li, C.Y-T.; Kong, A-N.T. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res., 2005, 28(3), 249-268.
[http://dx.doi.org/10.1007/BF02977789] [PMID: 15832810]

Schwartz, J.; Park, S.K.; O’Neill, M.S.; Vokonas, P.S.; Sparrow, D.; Weiss, S.; Kelsey, K. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am. J. Respir. Crit. Care Med., 2005, 172(12), 1529-1533.
[http://dx.doi.org/10.1164/rccm.200412-1698OC] [PMID: 16020798]

Ge, B.; Song, Y.; Zhang, Y.; Liu, X.; Wen, Y.; Guo, X. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysis. PLoS One, 2015, 10(3)e0118897
[http://dx.doi.org/10.1371/journal.pone.0118897] [PMID: 25742618]

Gong, M.; Dong, W.; Shi, Z.; Xu, Y.; Ni, W.; An, R. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies. PLoS One, 2012, 7(11)e50587
[http://dx.doi.org/10.1371/journal.pone.0050587] [PMID: 23189206]

Saeed, S.; Bonnefond, A.; Tamanini, F.; Mirza, M.U.; Manzoor, J.; Janjua, Q.M.; Din, S.M.; Gaitan, J.; Milochau, A.; Durand, E.; Vaillant, E.; Haseeb, A.; De Graeve, F.; Rabearivelo, I.; Sand, O.; Queniat, G.; Boutry, R.; Schott, D.A.; Ayesha, H.; Ali, M.; Khan, W.I.; Butt, T.A.; Rinne, T.; Stumpel, C.; Abderrahmani, A.; Lang, J.; Arslan, M.; Froguel, P. Loss-of-function mutations in ADCY3 cause monogenic severe obesity. Nat. Genet., 2018, 50(2), 175-179.
[http://dx.doi.org/10.1038/s41588-017-0023-6] [PMID: 29311637]

Grarup, N.; Moltke, I.; Andersen, M.K.; Dalby, M.; Vitting-Seerup, K.; Kern, T.; Mahendran, Y.; Jørsboe, E.; Larsen, C.V.L.; Dahl-Petersen, I.K.; Gilly, A.; Suveges, D.; Dedoussis, G.; Zeggini, E.; Pedersen, O.; Andersson, R.; Bjerregaard, P.; Jørgensen, M.E.; Albrechtsen, A.; Hansen, T. Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes. Nat. Genet., 2018, 50(2), 172-174.
[http://dx.doi.org/10.1038/s41588-017-0022-7] [PMID: 29311636]

Tomankova, V.; Anzenbacher, P.; Anzenbacherova, E. Effects of obesity on liver cytochromes P450 in various animal models Biomed. Pap. Med. Fa.c Univ. Palacky Olomouc, 2017, 161(2), 144-151.
[http://dx.doi.org/10.5507/bp.2017.026] [PMID: 28546638]

Almoshabek, H.A.; Mustafa, M.; Al-Asmari, M.M.; Alajmi, T.K.; Al-Asmari, A.K. Association of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms with obesity and their relationship with body mass index, lipoprotein and hypertension among young age Saudis. JRSM Cardiovasc. Dis., 2016, 52048004016669645
[http://dx.doi.org/10.1177/2048004016669645] [PMID: 27721975]

Savini, I.; Catani, M.V.; Evangelista, D.; Gasperi, V.; Avigliano, L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int. J. Mol. Sci., 2013, 14(5), 10497-10538.
[http://dx.doi.org/10.3390/ijms140510497] [PMID: 23698776]

Warolin, J.; Coenen, K.R.; Kantor, J.L.; Whitaker, L.E.; Wang, L.; Acra, S.A.; Roberts, L.J. II; Buchowski, M.S. The relationship of oxidative stress, adiposity and metabolic risk factors in healthy black and white American youth. Pediatr. Obes., 2014, 9(1), 43-52.
[http://dx.doi.org/10.1111/j.2047-6310.2012.00135.x] [PMID: 23296459]

Tran, B.; Oliver, S.; Rosa, J.; Galassetti, P. Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies. Exp. Diabetes Res., 2012, 2012683680
[http://dx.doi.org/10.1155/2012/683680] [PMID: 23093953]

Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114(12), 1752-1761.
[http://dx.doi.org/10.1172/JCI21625] [PMID: 15599400]

Strauss, R.S. Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J. Pediatr., 1999, 134(2), 160-165.
[http://dx.doi.org/10.1016/S0022-3476(99)70409-9] [PMID: 9931523]

Ortega, R.M.; Rodríguez-Rodríguez, E.; Aparicio, A.; Jiménez-Ortega, A.I.; Palmeros, C.; Perea, J.M.; Navia, B.; López-Sobaler, A.M. Young children with excess of weight show an impaired selenium status. Int. J. Vitam. Nutr. Res., 2012, 82(2), 121-129.
[http://dx.doi.org/10.1024/0300-9831/a000101] [PMID: 23065837]

Salvadori, A.; Fanari, P.; Fontana, M.; Buontempi, L.; Saezza, A.; Baudo, S.; Miserocchi, G.; Longhini, E. Oxygen uptake and cardiac performance in obese and normal subjects during exercise. Respiration, 1999, 66(1), 25-33.
[http://dx.doi.org/10.1159/000029333] [PMID: 9973687]

Wheatcroft, S.B.; Williams, I.L.; Shah, A.M.; Kearney, M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet. Med., 2003, 20(4), 255-268.
[http://dx.doi.org/10.1046/j.1464-5491.2003.00869.x] [PMID: 12675638]

Martínez, J.A. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J. Physiol. Biochem., 2006, 62(4), 303-306.
[http://dx.doi.org/10.1007/BF03165759] [PMID: 17615956]

Khan, N.I.; Naz, L.; Yasmeen, G. Obesity: an independent risk factor for systemic oxidative stress. Pak. J. Pharm. Sci., 2006, 19(1), 62-65.
[PMID: 16632456]

Manna, P.; Jain, S.K. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab. Syndr. Relat. Disord., 2015, 13(10), 423-444.
[http://dx.doi.org/10.1089/met.2015.0095] [PMID: 26569333]

Omrani, H.Q.; Shandiz, E.E.; Qabai, M.; Chaman, R.; Fard, H.A.; Qaffarpoor, M. Hyperhomocysteinemia, folateo and B12 vitamin in Iranian patients with acute ischemic stroke. ARYA Atheroscler., 2011, 7(3), 97-101.
[PMID: 22577454]

Nervana, M.; Bayoumy, M.M.; Khaled, A. Assessment of homocysteine plasma levels and insulin resistance among obese women with anovulatory infertility. Life Sci. J., 2012, 9(4), 1599-1604.

Wang, Y.; Li, X.; Qin, X.; Cai, Y.; He, M.; Sun, L.; Li, J.; Zhang, Y.; Tang, G.; Wang, B.; Sun, N.; Xu, X.; Liu, L.; Xu, X.; Huo, Y. Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years. Br. J. Nutr., 2013, 109(7), 1284-1293.
[http://dx.doi.org/10.1017/S0007114512003157] [PMID: 22850357]

Ganguly, P.; Alam, S.F. Role of homocysteine in the development of cardiovascular disease. Nutr. J., 2015, 14(1), 6.
[http://dx.doi.org/10.1186/1475-2891-14-6] [PMID: 25577237]

Fan, Y-L.; Zhan, R.; Dong, Y-F.; Huang, L.; Ji, X-X.; Lu, P.; Liu, J.; Li, P.; Cheng, X-S. Significant interaction of hypertension and homocysteine on neurological severity in first-ever ischemic stroke patients. J. Am. Soc. Hypertens., 2018, 12(7), 534-541.
[http://dx.doi.org/10.1016/j.jash.2018.03.011] [PMID: 29678422]

Kopelman, P. Health risks associated with overweight and obesity. Obes. Rev., 2007, 8(Suppl. 1), 13-17.
[http://dx.doi.org/10.1111/j.1467-789X.2007.00311.x] [PMID: 17316295]

den Heijer, M.; Rosendaal, F.R.; Blom, H.J.; Gerrits, W.B.; Bos, G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb. Haemost., 1998, 80(6), 874-877.
[http://dx.doi.org/10.1055/s-0037-1615380] [PMID: 9869152]

Nakazato, M.; Maeda, T.; Takamura, N.; Wada, M.; Yamasaki, H.; Johnston, K.E.; Tamura, T. Relation of body mass index to blood folate and total homocysteine concentrations in Japanese adults. Eur. J. Nutr., 2011, 50(7), 581-585.
[http://dx.doi.org/10.1007/s00394-010-0165-0] [PMID: 21221977]

Bays, H.E.; Toth, P.P.; Kris-Etherton, P.M.; Abate, N.; Aronne, L.J.; Brown, W.V.; Gonzalez-Campoy, J.M.; Jones, S.R.; Kumar, R.; La Forge, R.; Samuel, V.T. Obesity, adiposity, and dyslipidemia: a consensus statement from the national lipid association. J. Clin. Lipidol., 2013, 7(4), 304-383.
[http://dx.doi.org/10.1016/j.jacl.2013.04.001] [PMID: 23890517]

Goh, V.H.H.; Hart, W.G. Association of general and abdominal obesity with age, endocrine and metabolic factors in Asian men. Aging Male, 2016, 19(1), 27-33.
[http://dx.doi.org/10.3109/13685538.2015.1088825] [PMID: 26444311]

Xiao, C.; Dash, S.; Morgantini, C.; Hegele, R.A.; Lewis, G.F. Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol. Diabetes, 2016, 65(7), 1767-1778.
[http://dx.doi.org/10.2337/db16-0046] [PMID: 27329952]

Franssen, R.; Monajemi, H.; Stroes, E.S.; Kastelein, J.J. Obesity and dyslipidemia. Med. Clin. North Am., 2011, 95(5), 893-902.
[http://dx.doi.org/10.1016/j.mcna.2011.06.003] [PMID: 21855698]

Berneis, K.K.; Krauss, R.M. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res., 2002, 43(9), 1363-1379.
[http://dx.doi.org/10.1194/jlr.R200004-JLR200] [PMID: 12235168]

Masuda, D.; Yamashita, S. Postprandial hyperlipidemia and remnant lipoproteins. J. Atheroscler. Thromb., 2016, 24(2), 95-109.
[http://dx.doi.org/10.5551/jat.RV16003]] [PMID: 27829582]

Klop, B.; Elte, J.W.F.; Cabezas, M.C. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients, 2013, 5(4), 1218-1240.
[http://dx.doi.org/10.3390/nu5041218] [PMID: 23584084]

Skinner, A.C.; Perrin, E.M.; Moss, L.A.; Skelton, J.A. Cardiometabolic risks and severity of obesity in children and young adults. N. Engl. J. Med., 2015, 373(14), 1307-1317.
[http://dx.doi.org/10.1056/NEJMoa1502821] [PMID: 26422721]

Blottière, H.M.; de Vos, W.M.; Ehrlich, S.D.; Doré, J. Human intestinal metagenomics: state of the art and future. Curr. Opin. Microbiol., 2013, 16(3), 232-239.
[http://dx.doi.org/10.1016/j.mib.2013.06.006] [PMID: 23870802]

Vangay, P.; Ward, T.; Gerber, J.S.; Knights, D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe, 2015, 17(5), 553-564.
[http://dx.doi.org/10.1016/j.chom.2015.04.006] [PMID: 25974298]

Bäckhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA, 2004, 101(44), 15718-15723.
[http://dx.doi.org/10.1073/pnas.0407076101] [PMID: 15505215]

Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature, 2006, 444(7122), 1022-1023.
[http://dx.doi.org/10.1038/4441022a] [PMID: 17183309]

Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Human gut microbial ecology linked to obesity. Nature, 2006, 444, 1022-1023.
[http://dx.doi.org/10.1038/4441022a] [PMID: 17183309]

Cani, P.D.; Delzenne, N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des., 2009, 15(13), 1546-1558.
[http://dx.doi.org/10.2174/138161209788168164] [PMID: 19442172]

Cummings, D.E.; Schwartz, M.W. Genetics and pathophysiology of human obesity. Annu. Rev. Med., 2003, 54(1), 453-471.
[http://dx.doi.org/10.1146/annurev.med.54.101601.152403] [PMID: 12414915]

Kalil, G.Z.; Haynes, W.G. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens. Res., 2012, 35(1), 4-16.
[http://dx.doi.org/10.1038/hr.2011.173] [PMID: 22048570]

Grassi, G.; Seravalle, G.; Cattaneo, B.M.; Bolla, G.B.; Lanfranchi, A.; Colombo, M.; Giannattasio, C.; Brunani, A.; Cavagnini, F.; Mancia, G. Sympathetic activation in obese normotensive subjects. Hypertension, 1995, 25(4 Pt 1), 560-563.
[http://dx.doi.org/10.1161/01.HYP.25.4.560] [PMID: 7721398]

Shaffer, F.; Ginsberg, J.P. An overview of heart rate variability metrics and norms. Front. Public Health, 2017, 5, 258.
[http://dx.doi.org/10.3389/fpubh.2017.00258] [PMID: 29034226]

Yadav, R.L.; Yadav, P.K.; Yadav, L.K.; Agrawal, K.; Sah, S.K.; Islam, M.N. Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration - a risk of CVD. Diabetes Metab. Syndr. Obes., 2017, 10, 57-64.
[http://dx.doi.org/10.2147/DMSO.S123935] [PMID: 28255249]

Vanderlei, L.C.M.; Pastre, C.M.; Freitas Júnior, I.F.; Godoy, M.F. Analysis of cardiac autonomic modulation in obese and eutrophic children. Clinics (São Paulo), 2010, 65(8), 789-792.
[http://dx.doi.org/10.1590/S1807-59322010000800008] [PMID: 20835556]

Ko, G.T.; Chan, J.C.; Chan, A.W.; Wong, P.T.; Hui, S.S.; Tong, S.D.; Ng, S.M.; Chow, F.; Chan, C.L. Association between sleeping hours, working hours and obesity in Hong Kong Chinese: the ‘better health for better Hong Kong’ health promotion campaign. Int. J. Obes., 2007, 31(2), 254-260.
[http://dx.doi.org/10.1038/sj.ijo.0803389] [PMID: 16718283]

Baron, K.G.; Reid, K.J.; Kim, T.; Van Horn, L.; Attarian, H.; Wolfe, L.; Siddique, J.; Santostasi, G.; Zee, P.C. Circadian timing and alignment in healthy adults: associations with BMI, body fat, caloric intake and physical activity. Int. J. Obes., 2017, 41(2), 203-209.
[http://dx.doi.org/10.1038/ijo.2016.194] [PMID: 27795550]

Chaput, J.P.; Després, J.P.; Bouchard, C.; Tremblay, A. Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study. Obesity (Silver Spring), 2007, 15(1), 253-261.
[http://dx.doi.org/10.1038/oby.2007.512] [PMID: 17228054]

Cummings, D.E.; Foster, K.E. Ghrelin-leptin tango in body-weight regulation. Gastroenterology, 2003, 124(5), 1532-1535.
[http://dx.doi.org/10.1016/S0016-5085(03)00350-0] [PMID: 12730891]

Schwartz, M.W.; Morton, G. J. Obesity: keeping hunger at bay. Nature, 2002, 418(6898), 595-597.
[http://dx.doi.org/10.1038/418595a] [PMID: 12167841]

Taheri, S.; Lin, L.; Austin, D.; Young, T.; Mignot, E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med., 2004, 1(3)e62
[http://dx.doi.org/10.1371/journal.pmed.0010062] [PMID: 15602591]

Ayas, N.T.; White, D.P.; Al-Delaimy, W.K.; Manson, J.E.; Stampfer, M.J.; Speizer, F.E.; Patel, S.; Hu, F.B. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care, 2003, 26(2), 380-384.
[http://dx.doi.org/10.2337/diacare.26.2.380] [PMID: 12547866]

Horne, J. Short sleep is a questionable risk factor for obesity and related disorders: statistical versus clinical significance. Biol. Psychol., 2008, 77(3), 266-276.
[http://dx.doi.org/10.1016/j.biopsycho.2007.12.003] [PMID: 18243480]

Van Cauter, E.; Spiegel, K.; Tasali, E.; Leproult, R. Metabolic consequences of sleep and sleep loss. Sleep Med., 2008, 9(Suppl. 1), S23-S28.
[http://dx.doi.org/10.1016/S1389-9457(08)70013-3] [PMID: 18929315]

Harrison, Y.; Horne, J.A. Should we be taking more sleep? Sleep, 1995, 18(10), 901-907.
[PMID: 8746399]

Destors, M.; Tamisier, R.; Galerneau, L-M.; Lévy, P.; Pepin, J-L. Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences Presse Med., 2017, 46(4), 395-403.
[http://dx.doi.org/10.1016/j.lpm.2016.09.008] [PMID: 28126503]

Phillips, B.G.; Kato, M.; Narkiewicz, K.; Choe, I.; Somers, V.K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am. J. Physiol. Heart Circ. Physiol., 2000, 279(1), H234-H237.
[http://dx.doi.org/10.1152/ajpheart.2000.279.1.H234] [PMID: 10899061]

Jehan, S.; Auguste, E.; Zizi, F.; Pandi-Perumal, S.R.; Gupta, R.; Attarian, H.; Jean-Louis, G.; McFarlane, S.I. Obstructive sleep apnea: women’s perspective. J. Sleep Med. Disord., 2016, 3(6), 1064.
[PMID: 28239685]

Ulukavak Ciftci, T.; Kokturk, O.; Bukan, N.; Bilgihan, A. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration, 2005, 72(4), 395-401.
[http://dx.doi.org/10.1159/000086254] [PMID: 16088283]

Öztürk, L.; Ünal, M.; Tamer, L.; Çelikoğlu, F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch. Otolaryngol. Head Neck Surg., 2003, 129(5), 538-540.
[http://dx.doi.org/10.1001/archotol.129.5.538] [PMID: 12759266]

Carotenuto, M.; Santoro, N.; Grandone, A.; Santoro, E.; Pascotto, C.; Pascotto, A.; Perrone, L.; del Giudice, E.M. The insulin gene variable number of tandemrepeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity. J. Endocrinol. Invest., 2009, 32(9), 752-755.
[http://dx.doi.org/10.1007/BF03346531] [PMID: 19574727]

Carotenuto, M.; Bruni, O.; Santoro, N.; Del Giudice, E.M.; Perrone, L.; Pascotto, A. Waist circumference predicts the occurrence of sleep-disordered breathing in obese children and adolescents: a questionnaire-based study. Sleep Med., 2006, 7(4), 357-361.
[http://dx.doi.org/10.1016/j.sleep.2006.01.005] [PMID: 16713341]

Somers, V.K.; White, D.P.; Amin, R.; Abraham, W.T.; Costa, F.; Culebras, A.; Daniels, S.; Floras, J.S.; Hunt, C.E.; Olson, L.J.; Pickering, T.G.; Russell, R.; Woo, M.; Young, T. Sleep apnea and cardiovascular disease. J. Am. Coll. Cardiol., 2008, 52(8), 686-717.
[http://dx.doi.org/10.1016/j.jacc.2008.05.002] [PMID: 18702977]

Pearson, N.J.; Johnson, L.L.; Nahin, R.L. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch. Intern. Med., 2006, 166(16), 1775-1782.
[http://dx.doi.org/10.1001/archinte.166.16.1775] [PMID: 16983058]

Singareddy, R.; Vgontzas, A.N.; Fernandez-Mendoza, J.; Liao, D.; Calhoun, S.; Shaffer, M.L.; Bixler, E.O. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med., 2012, 13(4), 346-353.
[http://dx.doi.org/10.1016/j.sleep.2011.10.033] [PMID: 22425576]

Vgontzas, A.N.; Lin, H.M.; Papaliaga, M.; Calhoun, S.; Vela-Bueno, A.; Chrousos, G.P.; Bixler, E.O. Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int. J. Obes., 2008, 32(5), 801-809.
[http://dx.doi.org/10.1038/ijo.2008.4] [PMID: 18253159]

Laumann, E.O.; Paik, A.; Rosen, R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA, 1999, 281(6), 537-544.
[http://dx.doi.org/10.1001/jama.281.6.537] [PMID: 10022110]

Allison, K.C.; Lavery, M.E.; Sarwer, D.B. Obesity and reproductive functioning: psychiatric considerations. Prim. Psychiatry, 2009, 16(3), 35-40.

Sarwer, D.B.; Allison, K.C.; Gibbons, L.M.; Markowitz, J.T.; Nelson, D.B. Pregnancy and obesity: a review and agenda for future research. J. Womens Health (Larchmt.), 2006, 15(6), 720-733.
[http://dx.doi.org/10.1089/jwh.2006.15.720] [PMID: 16910904]

Leenen, R.; van der Kooy, K.; Seidell, J.C.; Deurenberg, P.; Koppeschaar, H.P. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J. Clin. Endocrinol. Metab., 1994, 78(6), 1515-1520.
[http://dx.doi.org/10.1210/jcem.78.6.8200956] [PMID: 8200956]

Strain, G.W.; Zumoff, B.; Miller, L.K.; Rosner, W. Sex difference in the effect of obesity on 24-hour mean serum gonadotropin levels. Horm. Metab. Res., 2003, 35(6), 362-366.
[http://dx.doi.org/10.1055/s-2003-41358] [PMID: 12920659]

Aversa, A.; Isidori, A.M.; De Martino, M.U.; Caprio, M.; Fabbrini, E.; Rocchietti-March, M.; Frajese, G.; Fabbri, A. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin. Endocrinol. (Oxf.), 2000, 53(4), 517-522.
[http://dx.doi.org/10.1046/j.1365-2265.2000.01118.x] [PMID: 11012578]

Pears, J.; Jung, R.T.; Gunn, A. Long-term weight changes in treated hyperthyroid and hypothyroid patients. Scott. Med. J., 1990, 35(6), 180-182.
[http://dx.doi.org/10.1177/003693309003500609] [PMID: 2077652]

Dale, J.; Daykin, J.; Holder, R.; Sheppard, M.C.; Franklyn, J.A. Weight gain following treatment of hyperthyroidism. Clin. Endocrinol. (Oxf.), 2001, 55(2), 233-239.
[http://dx.doi.org/10.1046/j.1365-2265.2001.01329.x] [PMID: 11531931]

Xanthakos, S.A. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr. Clin. North Am., 2009, 56(5), 1105-1121.
[http://dx.doi.org/10.1016/j.pcl.2009.07.002] [PMID: 19931066]

Davison, K.M.; Gondara, L.; Kaplan, B.J. Food insecurity, poor diet quality, and suboptimal intakes of folate and iron are independently associated with perceived mental health in Canadian adults. Nutrients, 2017, 9(3), 274.
[http://dx.doi.org/10.3390/nu9030274] [PMID: 28335418]

McGuire, S. Scientific report of the 2015 dietary guidelines advisory committee. Washington, DC: US departments of agriculture and health and human services, 2015. Adv. Nutr., 2016, 7(1), 202-204.
[http://dx.doi.org/10.3945/an.115.011684] [PMID: 26773024]

Cutler, D.M.; Glaeser, E.L.; Shapiro, J.M. Why have Americans become more obese? J. Econ. Perspect., 2003, 17(3), 93-118.
[http://dx.doi.org/10.1257/089533003769204371]

De Baerdemaeker, L.E.; Mortier, E.P.; Struys, M.M. Pharmacokinetics in obese patients. Contin. Educ. Anaesth. Crit. Care Pain, 2004, 4(5), 152-155.
[http://dx.doi.org/10.1093/bjaceaccp/mkh042]

Agarwal, S.; Reider, C.; Brooks, J.R.; Fulgoni, V.L. III. Comparison of prevalence of inadequate nutrient intake based on body weight status of adults in the United States: an analysis of NHANES 2001-2008. J. Am. Coll. Nutr., 2015, 34(2), 126-134.
[http://dx.doi.org/10.1080/07315724.2014.901196] [PMID: 25564766]

Zuckerman, M.; Greller, H.A.; Babu, K.M. A review of the toxicologic implications of obesity. J. Med. Toxicol., 2015, 11(3), 342-354.
[http://dx.doi.org/10.1007/s13181-015-0488-6] [PMID: 26108709]

Blouin, R.A.; Kolpek, J.H.; Mann, H.J. Influence of obesity on drug disposition. Clin. Pharm., 1987, 6(9), 706-714.
[PMID: 3315402]

Liel, Y.; Ulmer, E.; Shary, J.; Hollis, B.W.; Bell, N.H. Low circulating vitamin D in obesity. Calcif. Tissue Int., 1988, 43(4), 199-201.
[http://dx.doi.org/10.1007/BF02555135] [PMID: 3145124]

Wortsman, J.; Matsuoka, L.Y.; Chen, T.C.; Lu, Z.; Holick, M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr., 2000, 72(3), 690-693.
[http://dx.doi.org/10.1093/ajcn/72.3.690] [PMID: 10966885]

Drincic, A.T.; Armas, L.A.; Van Diest, E.E.; Heaney, R.P. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring), 2012, 20(7), 1444-1448.
[http://dx.doi.org/10.1038/oby.2011.404] [PMID: 22262154]

Tremblay, A.; Chaput, J-P. About unsuspected potential determinants of obesity. Appl. Physiol. Nutr. Metab., 2008, 33(4), 791-796.
[http://dx.doi.org/10.1139/H08-038] [PMID: 18641724]

Astrup, A.; Bügel, S. Micronutrient deficiency in the aetiology of obesity. Int. J. Obes., 2010, 34(6), 947-948.
[http://dx.doi.org/10.1038/ijo.2010.81] [PMID: 20543852]

García, O.P.; Long, K.Z.; Rosado, J.L. Impact of micronutrient deficiencies on obesity. Nutr. Rev., 2009, 67(10), 559-572.
[http://dx.doi.org/10.1111/j.1753-4887.2009.00228.x] [PMID: 19785688]

Leech, R.M.; McNaughton, S.A.; Timperio, A. The clustering of diet, physical activity and sedentary behavior in children and adolescents: a review. Int. J. Behav. Nutr. Phys. Act., 2014, 11(1), 4.
[http://dx.doi.org/10.1186/1479-5868-11-4] [PMID: 24450617]

Enes, C.C.; Slater, B. Obesity in adolescence and its main determinants Rev. Bras. Epidemiol., 2010, 13(1), 163-171.
[http://dx.doi.org/10.1590/S1415-790X2010000100015] [PMID: 20683564]

Manson, J.E.; Skerrett, P.J.; Greenland, P.; VanItallie, T.B. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch. Intern. Med., 2004, 164(3), 249-258.
[http://dx.doi.org/10.1001/archinte.164.3.249] [PMID: 14769621]

Jebb, S.A.; Moore, M.S. Contribution of a sedentary lifestyle and inactivity to the etiology of overweight and obesity: current evidence and research issues. Med. Sci. Sports Exerc., 1999, 31(11)(Suppl.), S534-S541.
[http://dx.doi.org/10.1097/00005768-199911001-00008] [PMID: 10593524]

Ziviani, J.; Scott, J.; Wadley, D. Walking to school: incidental physical activity in the daily occupations of Australian children. Occup. Ther. Int., 2004, 11(1), 1-11.
[http://dx.doi.org/10.1002/oti.193] [PMID: 15118767]

O’Rahilly, S.; Farooqi, I.S.; Yeo, G.S.; Challis, B.G. Minireview: human obesity-lessons from monogenic disorders. Endocrinology, 2003, 144(9), 3757-3764.
[http://dx.doi.org/10.1210/en.2003-0373] [PMID: 12933645]

Locke, A.E.; Kahali, B.; Berndt, S.I.; Justice, A.E.; Pers, T.H.; Day, F.R.; Powell, C.; Vedantam, S.; Buchkovich, M.L.; Yang, J.; Croteau-Chonka, D.C.; Esko, T.; Fall, T.; Ferreira, T.; Gustafsson, S.; Kutalik, Z.; Luan, J.; Mägi, R.; Randall, J.C.; Winkler, T.W.; Wood, A.R.; Workalemahu, T.; Faul, J.D.; Smith, J.A.; Zhao, J.H.; Zhao, W.; Chen, J.; Fehrmann, R.; Hedman, Å.K.; Karjalainen, J.; Schmidt, E.M.; Absher, D.; Amin, N.; Anderson, D.; Beekman, M.; Bolton, J.L.; Bragg-Gresham, J.L.; Buyske, S.; Demirkan, A.; Deng, G.; Ehret, G.B.; Feenstra, B.; Feitosa, M.F.; Fischer, K.; Goel, A.; Gong, J.; Jackson, A.U.; Kanoni, S.; Kleber, M.E.; Kristiansson, K.; Lim, U.; Lotay, V.; Mangino, M.; Leach, I.M.; Medina-Gomez, C.; Medland, S.E.; Nalls, M.A.; Palmer, C.D.; Pasko, D.; Pechlivanis, S.; Peters, M.J.; Prokopenko, I.; Shungin, D.; Stančáková, A.; Strawbridge, R.J.; Sung, Y.J.; Tanaka, T.; Teumer, A.; Trompet, S.; van der Laan, S.W.; van Setten, J.; Van Vliet-Ostaptchouk, J.V.; Wang, Z.; Yengo, L.; Zhang, W.; Isaacs, A.; Albrecht, E.; Ärnlöv, J.; Arscott, G.M.; Attwood, A.P.; Bandinelli, S.; Barrett, A.; Bas, I.N.; Bellis, C.; Bennett, A.J.; Berne, C.; Blagieva, R.; Blüher, M.; Böhringer, S.; Bonnycastle, L.L.; Böttcher, Y.; Boyd, H.A.; Bruinenberg, M.; Caspersen, I.H.; Chen, Y.I.; Clarke, R.; Daw, E.W.; de Craen, A.J.M.; Delgado, G.; Dimitriou, M.; Doney, A.S.F.; Eklund, N.; Estrada, K.; Eury, E.; Folkersen, L.; Fraser, R.M.; Garcia, M.E.; Geller, F.; Giedraitis, V.; Gigante, B.; Go, A.S.; Golay, A.; Goodall, A.H.; Gordon, S.D.; Gorski, M.; Grabe, H.J.; Grallert, H.; Grammer, T.B.; Gräßler, J.; Grönberg, H.; Groves, C.J.; Gusto, G.; Haessler, J.; Hall, P.; Haller, T.; Hallmans, G.; Hartman, C.A.; Hassinen, M.; Hayward, C.; Heard-Costa, N.L.; Helmer, Q.; Hengstenberg, C.; Holmen, O.; Hottenga, J.J.; James, A.L.; Jeff, J.M.; Johansson, Å.; Jolley, J.; Juliusdottir, T.; Kinnunen, L.; Koenig, W.; Koskenvuo, M.; Kratzer, W.; Laitinen, J.; Lamina, C.; Leander, K.; Lee, N.R.; Lichtner, P.; Lind, L.; Lindström, J.; Lo, K.S.; Lobbens, S.; Lorbeer, R.; Lu, Y.; Mach, F.; Magnusson, P.K.E.; Mahajan, A.; McArdle, W.L.; McLachlan, S.; Menni, C.; Merger, S.; Mihailov, E.; Milani, L.; Moayyeri, A.; Monda, K.L.; Morken, M.A.; Mulas, A.; Müller, G.; Müller-Nurasyid, M.; Musk, A.W.; Nagaraja, R.; Nöthen, M.M.; Nolte, I.M.; Pilz, S.; Rayner, N.W.; Renstrom, F.; Rettig, R.; Ried, J.S.; Ripke, S.; Robertson, N.R.; Rose, L.M.; Sanna, S.; Scharnagl, H.; Scholtens, S.; Schumacher, F.R.; Scott, W.R.; Seufferlein, T.; Shi, J.; Smith, A.V.; Smolonska, J.; Stanton, A.V.; Steinthorsdottir, V.; Stirrups, K.; Stringham, H.M.; Sundström, J.; Swertz, M.A.; Swift, A.J.; Syvänen, A.C.; Tan, S.T.; Tayo, B.O.; Thorand, B.; Thorleifsson, G.; Tyrer, J.P.; Uh, H.W.; Vandenput, L.; Verhulst, F.C.; Vermeulen, S.H.; Verweij, N.; Vonk, J.M.; Waite, L.L.; Warren, H.R.; Waterworth, D.; Weedon, M.N.; Wilkens, L.R.; Willenborg, C.; Wilsgaard, T.; Wojczynski, M.K.; Wong, A.; Wright, A.F.; Zhang, Q.; Brennan, E.P.; Choi, M.; Dastani, Z.; Drong, A.W.; Eriksson, P.; Franco-Cereceda, A.; Gådin, J.R.; Gharavi, A.G.; Goddard, M.E.; Handsaker, R.E.; Huang, J.; Karpe, F.; Kathiresan, S.; Keildson, S.; Kiryluk, K.; Kubo, M.; Lee, J.Y.; Liang, L.; Lifton, R.P.; Ma, B.; McCarroll, S.A.; McKnight, A.J.; Min, J.L.; Moffatt, M.F.; Montgomery, G.W.; Murabito, J.M.; Nicholson, G.; Nyholt, D.R.; Okada, Y.; Perry, J.R.B.; Dorajoo, R.; Reinmaa, E.; Salem, R.M.; Sandholm, N.; Scott, R.A.; Stolk, L.; Takahashi, A.; Tanaka, T.; van ’t Hooft, F.M.; Vinkhuyzen, A.A.E.; Westra, H.J.; Zheng, W.; Zondervan, K.T.; Heath, A.C.; Arveiler, D.; Bakker, S.J.L.; Beilby, J.; Bergman, R.N.; Blangero, J.; Bovet, P.; Campbell, H.; Caulfield, M.J.; Cesana, G.; Chakravarti, A.; Chasman, D.I.; Chines, P.S.; Collins, F.S.; Crawford, D.C.; Cupples, L.A.; Cusi, D.; Danesh, J.; de Faire, U.; den Ruijter, H.M.; Dominiczak, A.F.; Erbel, R.; Erdmann, J.; Eriksson, J.G.; Farrall, M.; Felix, S.B.; Ferrannini, E.; Ferrières, J.; Ford, I.; Forouhi, N.G.; Forrester, T.; Franco, O.H.; Gansevoort, R.T.; Gejman, P.V.; Gieger, C.; Gottesman, O.; Gudnason, V.; Gyllensten, U.; Hall, A.S.; Harris, T.B.; Hattersley, A.T.; Hicks, A.A.; Hindorff, L.A.; Hingorani, A.D.; Hofman, A.; Homuth, G.; Hovingh, G.K.; Humphries, S.E.; Hunt, S.C.; Hyppönen, E.; Illig, T.; Jacobs, K.B.; Jarvelin, M.R.; Jöckel, K.H.; Johansen, B.; Jousilahti, P.; Jukema, J.W.; Jula, A.M.; Kaprio, J.; Kastelein, J.J.P.; Keinanen-Kiukaanniemi, S.M.; Kiemeney, L.A.; Knekt, P.; Kooner, J.S.; Kooperberg, C.; Kovacs, P.; Kraja, A.T.; Kumari, M.; Kuusisto, J.; Lakka, T.A.; Langenberg, C.; Marchand, L.L.; Lehtimäki, T.; Lyssenko, V.; Männistö, S.; Marette, A.; Matise, T.C.; McKenzie, C.A.; McKnight, B.; Moll, F.L.; Morris, A.D.; Morris, A.P.; Murray, J.C.; Nelis, M.; Ohlsson, C.; Oldehinkel, A.J.; Ong, K.K.; Madden, P.A.F.; Pasterkamp, G.; Peden, J.F.; Peters, A.; Postma, D.S.; Pramstaller, P.P.; Price, J.F.; Qi, L.; Raitakari, O.T.; Rankinen, T.; Rao, D.C.; Rice, T.K.; Ridker, P.M.; Rioux, J.D.; Ritchie, M.D.; Rudan, I.; Salomaa, V.; Samani, N.J.; Saramies, J.; Sarzynski, M.A.; Schunkert, H.; Schwarz, P.E.H.; Sever, P.; Shuldiner, A.R.; Sinisalo, J.; Stolk, R.P.; Strauch, K.; Tönjes, A.; Trégouët, D.A.; Tremblay, A.; Tremoli, E.; Virtamo, J.; Vohl, M.C.; Völker, U.; Waeber, G.; Willemsen, G.; Witteman, J.C.; Zillikens, M.C.; Adair, L.S.; Amouyel, P.; Asselbergs, F.W.; Assimes, T.L.; Bochud, M.; Boehm, B.O.; Boerwinkle, E.; Bornstein, S.R.; Bottinger, E.P.; Bouchard, C.; Cauchi, S.; Chambers, J.C.; Chanock, S.J.; Cooper, R.S.; de Bakker, P.I.W.; Dedoussis, G.; Ferrucci, L.; Franks, P.W.; Froguel, P.; Groop, L.C.; Haiman, C.A.; Hamsten, A.; Hui, J.; Hunter, D.J.; Hveem, K.; Kaplan, R.C.; Kivimaki, M.; Kuh, D.; Laakso, M.; Liu, Y.; Martin, N.G.; März, W.; Melbye, M.; Metspalu, A.; Moebus, S.; Munroe, P.B.; Njølstad, I.; Oostra, B.A.; Palmer, C.N.A.; Pedersen, N.L.; Perola, M.; Pérusse, L.; Peters, U.; Power, C.; Quertermous, T.; Rauramaa, R.; Rivadeneira, F.; Saaristo, T.E.; Saleheen, D.; Sattar, N.; Schadt, E.E.; Schlessinger, D.; Slagboom, P.E.; Snieder, H.; Spector, T.D.; Thorsteinsdottir, U.; Stumvoll, M.; Tuomilehto, J.; Uitterlinden, A.G.; Uusitupa, M.; van der Harst, P.; Walker, M.; Wallaschofski, H.; Wareham, N.J.; Watkins, H.; Weir, D.R.; Wichmann, H.E.; Wilson, J.F.; Zanen, P.; Borecki, I.B.; Deloukas, P.; Fox, C.S.; Heid, I.M.; O’Connell, J.R.; Strachan, D.P.; Stefansson, K.; van Duijn, C.M.; Abecasis, G.R.; Franke, L.; Frayling, T.M.; McCarthy, M.I.; Visscher, P.M.; Scherag, A.; Willer, C.J.; Boehnke, M.; Mohlke, K.L.; Lindgren, C.M.; Beckmann, J.S.; Barroso, I.; North, K.E.; Ingelsson, E.; Hirschhorn, J.N.; Loos, R.J.F.; Speliotes, E.K. LifeLines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature, 2015, 518(7538), 197-206.
[http://dx.doi.org/10.1038/nature14177] [PMID: 25673413]

Silventoinen, K.; Jelenkovic, A.; Sund, R.; Yokoyama, Y.; Hur, Y-M.; Cozen, W.; Hwang, A.E.; Mack, T.M.; Honda, C.; Inui, F.; Iwatani, Y.; Watanabe, M.; Tomizawa, R.; Pietiläinen, K.H.; Rissanen, A.; Siribaddana, S.H.; Hotopf, M.; Sumathipala, A.; Rijsdijk, F.; Tan, Q.; Zhang, D.; Pang, Z.; Piirtola, M.; Aaltonen, S.; Öncel, S.Y.; Aliev, F.; Rebato, E.; Hjelmborg, J.B.; Christensen, K.; Skytthe, A.; Kyvik, K.O.; Silberg, J.L.; Eaves, L.J.; Cutler, T.L.; Ordoñana, J.R.; Sánchez-Romera, J.F.; Colodro-Conde, L.; Song, Y.M.; Yang, S.; Lee, K.; Franz, C.E.; Kremen, W.S.; Lyons, M.J.; Busjahn, A.; Nelson, T.L.; Whitfield, K.E.; Kandler, C.; Jang, K.L.; Gatz, M.; Butler, D.A.; Stazi, M.A.; Fagnani, C.; D’Ippolito, C.; Duncan, G.E.; Buchwald, D.; Martin, N.G.; Medland, S.E.; Montgomery, G.W.; Jeong, H.U.; Swan, G.E.; Krasnow, R.; Magnusson, P.K.; Pedersen, N.L.; Dahl Aslan, A.K.; McAdams, T.A.; Eley, T.C.; Gregory, A.M.; Tynelius, P.; Baker, L.A.; Tuvblad, C.; Bayasgalan, G.; Narandalai, D.; Spector, T.D.; Mangino, M.; Lachance, G.; Burt, S.A.; Klump, K.L.; Harris, J.R.; Brandt, I.; Nilsen, T.S.; Krueger, R.F.; McGue, M.; Pahlen, S.; Corley, R.P.; Huibregtse, B.M.; Bartels, M.; van Beijsterveldt, C.E.; Willemsen, G.; Goldberg, J.H.; Rasmussen, F.; Tarnoki, A.D.; Tarnoki, D.L.; Derom, C.A.; Vlietinck, R.F.; Loos, R.J.; Hopper, J.L.; Sung, J.; Maes, H.H.; Turkheimer, E.; Boomsma, D.I.; Sørensen, T.I.; Kaprio, J. Differences in genetic and environmental variation in adult BMI by sex, age, time period, and region: an individual-based pooled analysis of 40 twin cohorts. Am. J. Clin. Nutr., 2017, 106(2), 457-466.
[http://dx.doi.org/10.3945/ajcn.117.153643] [PMID: 28679550]

Han, J.C. Rare syndromes and common variants of the brain-derived neurotrophic factor gene in human obesity. Prog. Mol. Biol. Transl. Sci., 2016, 140, 75-95.
[http://dx.doi.org/10.1016/bs.pmbts.2015.12.002] [PMID: 27288826]

Danielle, F.; Neilsen, B.; Costanzo-Garvey, D.; Fisher, K.; Lewis, R. Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras. F1000 Res., 2017, 6, 1621.
[http://dx.doi.org/10.12688/f1000research.11895.1 ] [PMID: 29026529 ]

Wasim, M.; Awan, F.R.; Najam, S.S.; Khan, A.R.; Khan, H.N. Role of leptin deficiency, inefficiency, and leptin receptors in obesity. Biochem. Genet., 2016, 54(5), 565-572.
[http://dx.doi.org/10.1007/s10528-016-9751-z] [PMID: 27313173]

Reddon, H.; Gerstein, H.C.; Engert, J.C.; Mohan, V.; Bosch, J.; Desai, D.; Bailey, S.D.; Diaz, R.; Yusuf, S.; Anand, S.S.; Meyre, D. Physical activity and genetic predisposition to obesity in a multiethnic longitudinal study. Sci. Rep., 2016, 6, 18672.
[http://dx.doi.org/10.1038/srep18672] [PMID: 26727462]

Xiang, L.; Wu, H.; Pan, A.; Patel, B.; Xiang, G.; Qi, L.; Kaplan, R.C.; Hu, F.; Wylie-Rosett, J.; Qi, Q. FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis. Am. J. Clin. Nutr., 2016, 103(4), 1162-1170.
[http://dx.doi.org/10.3945/ajcn.115.123448] [PMID: 26888713]

Bray, M.S.; Loos, R.J.; McCaffery, J.M.; Ling, C.; Franks, P.W.; Weinstock, G.M.; Snyder, M.P.; Vassy, J.L.; Agurs-Collins, T. Conference Working Group. NIH working group report-using genomic information to guide weight management: From universal to precision treatment. Obesity (Silver Spring), 2016, 24(1), 14-22.
[http://dx.doi.org/10.1002/oby.21381] [PMID: 26692578]

Kai, A.K.; Lam, A.K.; Chen, Y.; Tai, A.C.; Zhang, X.; Lai, A.K.; Yeung, P.K.; Tam, S.; Wang, J.; Lam, K.S.; Vanhoutte, P.M.; Bos, J.L.; Chung, S.S.; Xu, A.; Chung, S.K. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB J., 2013, 27(10), 4122-4135.
[http://dx.doi.org/10.1096/fj.13-230433] [PMID: 23825225]

Hu, Y.; Robichaux, W.G., III; Mei, F.C.; Kim, E.R.; Wang, H.; Tong, Q.; Jin, J.; Xu, M.; Chen, J.; Cheng, X. Role of exchange protein directly activated by cyclic AMP isoform 1 in energy homeostasis: regulation of leptin expression and secretion in white adipose tissue. Mol. Cell. Biol., 2016, 36(19), 2440-2450.
[http://dx.doi.org/10.1128/MCB.01034-15] [PMID: 27381457]

Komai, A.M.; Musovic, S.; Peris, E.; Alrifaiy, A.; El Hachmane, M.F.; Johansson, M.; Wernstedt Asterholm, I.; Olofsson, C.S. White adipocyte adiponectin exocytosis is stimulated via β3-adrenergic signaling and activation of Epac1: catecholamine resistance in obesity and type 2 diabetes. Diabetes, 2016, 65(11), 3301-3313.
[http://dx.doi.org/10.2337/db15-1597] [PMID: 27554468]

Lesseur, C.; Armstrong, D.A.; Paquette, A.G.; Koestler, D.C.; Padbury, J.F.; Marsit, C.J. Tissue-specific leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol. Cell. Endocrinol., 2013, 381(1-2), 160-167.
[http://dx.doi.org/10.1016/j.mce.2013.07.024] [PMID: 23911897]

Thaker, V.V. genetic and epigenetic causes of obesity. Adolesc. Med. State Art Rev., 2017, 28(2), 379-405.
[PMID: 30416642]

Crujeiras, A.B.; Campion, J.; Díaz-Lagares, A.; Milagro, F.I.; Goyenechea, E.; Abete, I.; Casanueva, F.F.; Martínez, J.A. Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul. Pept., 2013, 186, 1-6.
[http://dx.doi.org/10.1016/j.regpep.2013.06.012] [PMID: 23831408]

Yoo, J.Y.; Lee, S.; Lee, H.A.; Park, H.; Park, Y.J.; Ha, E.H.; Kim, Y.J. Can proopiomelanocortin methylation be used as an early predictor of metabolic syndrome? Diabetes Care, 2014, 37(3), 734-739.
[http://dx.doi.org/10.2337/dc13-1012] [PMID: 24222450]

Zhang, Q.; Ramlee, M.K.; Brunmeir, R.; Villanueva, C.J.; Halperin, D.; Xu, F. Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes. Cell Cycle, 2012, 11(23), 4310-4322.
[http://dx.doi.org/10.4161/cc.22224] [PMID: 23085542]

Prats-Puig, A.; Ortega, F.J.; Mercader, J.M.; Moreno-Navarrete, J.M.; Moreno, M.; Bonet, N.; Ricart, W.; López-Bermejo, A.; Fernández-Real, J.M. Changes in circulating microRNAs are associated with childhood obesity. J. Clin. Endocrinol. Metab., 2013, 98(10), E1655-E1660.
[http://dx.doi.org/10.1210/jc.2013-1496] [PMID: 23928666]

Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136(2), 215-233.
[http://dx.doi.org/10.1016/j.cell.2009.01.002] [PMID: 19167326]

Zhao, H.; Shen, J.; Daniel-MacDougall, C.; Wu, X.; Chow, W.H. Plasma MicroRNA signature predicting weight gain among Mexican-American women. Obesity (Silver Spring), 2017, 25(5), 958-964.
[http://dx.doi.org/10.1002/oby.21824] [PMID: 28342299]

Heneghan, H.M.; Miller, N.; Kerin, M.J. Role of microRNAs in obesity and the metabolic syndrome. Obes. Rev., 2010, 11(5), 354-361.
[http://dx.doi.org/10.1111/j.1467-789X.2009.00659.x] [PMID: 19793375]

Fernandez-Valverde, S.L.; Taft, R.J.; Mattick, J.S. MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes, 2011, 60(7), 1825-1831.
[http://dx.doi.org/10.2337/db11-0171] [PMID: 21709277]

Arroyo, J.D.; Chevillet, J.R.; Kroh, E.M.; Ruf, I.K.; Pritchard, C.C.; Gibson, D.F.; Mitchell, P.S.; Bennett, C.F.; Pogosova-Agadjanyan, E.L.; Stirewalt, D.L.; Tait, J.F.; Tewari, M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA, 2011, 108(12), 5003-5008.
[http://dx.doi.org/10.1073/pnas.1019055108] [PMID: 21383194]

Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. cell Bio, 2007, 9(6), 654-659.
[http://dx.doi.org/10.1038/ncb1596] [PMID: 17486113]

Vickers, K.C.; Palmisano, B.T.; Shoucri, B.M.; Shamburek, R.D.; Remaley, A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat. cell Bio, 2011, 13(4), 423-433.
[http://dx.doi.org/10.1038/ncb2210] [PMID: 21423178]

Ortega, F.J.; Mercader, J.M.; Catalán, V.; Moreno-Navarrete, J.M.; Pueyo, N.; Sabater, M.; Gómez-Ambrosi, J.; Anglada, R.; Fernández-Formoso, J.A.; Ricart, W.; Frühbeck, G.; Fernández-Real, J.M. Targeting the circulating microRNA signature of obesity. Clin. Chem., 2013, 59(5), 781-792.
[http://dx.doi.org/10.1373/clinchem.2012.195776] [PMID: 23396142]

Karolina, D.S.; Tavintharan, S.; Armugam, A.; Sepramaniam, S.; Pek, S.L.T.; Wong, M.T.; Lim, S.C.; Sum, C.F.; Jeyaseelan, K. Circulating miRNA profiles in patients with metabolic syndrome. J. Clin. Endocrinol. Metab., 2012, 97(12), E2271-E2276.
[http://dx.doi.org/10.1210/jc.2012-1996] [PMID: 23032062]

Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res., 2010, 107(6), 810-817.
[http://dx.doi.org/10.1161/CIRCRESAHA.110.226357] [PMID: 20651284]

Fain, J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the non-fat cells. Vitam. Horm., 2006, 74, 443-477.
[http://dx.doi.org/10.1016/S0083-6729(06)74018-3] [PMID: 17027526]

Zhang, J-M.; An, J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin., 2007, 45(2), 27-37.
[http://dx.doi.org/10.1097/AIA.0b013e318034194e] [PMID: 17426506]

Maachi, M.; Piéroni, L.; Bruckert, E.; Jardel, C.; Fellahi, S.; Hainque, B.; Capeau, J.; Bastard, J.P. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int. J. Obes. Relat. Metab. Disord., 2004, 28(8), 993-997.
[http://dx.doi.org/10.1038/sj.ijo.0802718] [PMID: 15211360]

Alexandraki, K.I.; Piperi, C.; Ziakas, P.D.; Apostolopoulos, N.V.; Makrilakis, K.; Syriou, V.; Diamanti-Kandarakis, E.; Kaltsas, G.; Kalofoutis, A. Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J. Clin. Immunol., 2008, 28(4), 314-321.
[http://dx.doi.org/10.1007/s10875-007-9164-1] [PMID: 18224429]

Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol., 2003, 3(1), 23-35.
[http://dx.doi.org/10.1038/nri978] [PMID: 12511873]

Ye, J. Mechanisms of insulin resistance in obesity. Front. Med., 2013, 7(1), 14-24.
[http://dx.doi.org/10.1007/s11684-013-0262-6] [PMID: 23471659]

Castro, A.; Macedo-de la Concha, L.; Pantoja-Meléndez, C. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev. Med. Hosp. Gen. (Mex.), 2017, 80(2), 101-105.
[http://dx.doi.org/10.1016/j.hgmx.2016.06.011]

Ota, T. Chemokine systems link obesity to insulin resistance. Diabetes Metab. J., 2013, 37(3), 165-172.
[http://dx.doi.org/10.4093/dmj.2013.37.3.165] [PMID: 23807918]

Russell-Jones, D.; Khan, R. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes. Metab., 2007, 9(6), 799-812.
[http://dx.doi.org/10.1111/j.1463-1326.2006.00686.x] [PMID: 17924864]

Alemán-González-Duhart, D.; Tamay-Cach, F.; Álvarez-Almazán, S.; Mendieta-Wejebe, J.E. Current advances in the biochemical and physiological aspects of the treatment of type 2 diabetes mellitus with thiazolidinediones. PPAR Res., 2016, 20167614270
[http://dx.doi.org/10.1155/2016/7614270] [PMID: 27313601]

Sharma, A.M.; Pischon, T.; Hardt, S.; Kunz, I.; Luft, F.C. Hypothesis: β-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension, 2001, 37(2), 250-254.
[http://dx.doi.org/10.1161/01.HYP.37.2.250] [PMID: 11230280]

Manconi, F.; Zuddas, A.; Piccardi, M.; Del Zompo, M.; Corsini, G. Behavioural and biochemical effects of flunarizine on the dopaminergic system in rodents. Cephalalgia, 1987, 7(6), 420-421.
[http://dx.doi.org/10.1177/03331024870070S6185]

Larsen, P.J.; Jessop, D.S.; Chowdrey, H.S.; Lightman, S.L.; Mikkelsen, J.D. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J. Neuroendocrinol., 1994, 6(2), 153-159.
[http://dx.doi.org/10.1111/j.1365-2826.1994.tb00566.x] [PMID: 8049712]

Chen, D.; Misra, A.; Garg, A. Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J. Clin. Endocrinol. Metab., 2002, 87(11), 4845-4856.
[http://dx.doi.org/10.1210/jc.2002-020794] [PMID: 12414837]

Ballon, J.S.; Pajvani, U.; Freyberg, Z.; Leibel, R.L.; Lieberman, J.A. Molecular pathophysiology of metabolic effects of antipsychotic medications. Trends Endocrinol. Metab., 2014, 25(11), 593-600.
[http://dx.doi.org/10.1016/j.tem.2014.07.004] [PMID: 25190097]

Serretti, A.; Mandelli, L. Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry, 2010, 71(10), 1259-1272.
[http://dx.doi.org/10.4088/JCP.09r05346blu] [PMID: 21062615]

Masand, P.S.; Gupta, S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann. Clin. Psychiatry, 2002, 14(3), 175-182.
[http://dx.doi.org/10.3109/10401230209147454] [PMID: 12585567]